News from us and our partners

Tags

Topics

0 results

News
5 June, 2024
Moon Surgical receives second FDA clearance, covering its commercial Maestro™ surgical robotics system
News
4 June, 2024
Afyren provides business update on its Afyren Neoxy plant
News
3 June, 2024
HighLife receives IDE approval to initiate US pivotal clinical study for treatment of mitral regurgitation
News
3 June, 2024
GenSight Biologics appoints William Monteith to its Board of Directors
News
31 May, 2024
Johnson & Johnson completes acquisition of Shockwave Medical
News
28 May, 2024
Asahi Kasei to acquire Calliditas Therapeutics AB to accelerate growth as a global healthcare company
News
28 May, 2024
Elicit Plant accelerates its international expansion in response to climate change and challenges in the agricultural sector
News
28 May, 2024
Statement by the Board of Directors of Calliditas Therapeutics AB (publ) in relation to the public offer by Asahi Kasei Corporation
News
28 May, 2024
NodThera announces appointment of Daniel Swisher as Chief Executive Officer
News
22 May, 2024
Noema Pharma announces first patient dosed in Phase 2a Study of NOE-115, a first-in-class investigational therapy for the treatment of vasomotor symptoms and additional symptoms associated with menopause
News
21 May, 2024
Inspirna announces appointment of Karim Benhadji, M.D., as Chief Medical Officer and retirement of Robert Wasserman, M.D.
News
21 May, 2024
Qorium bolsters Board with appointment of Elizabeth Bastoni and Martin Brok, renowned experts in the consumer goods and retail sectors
News
16 May, 2024
Inventiva announces the positive recommendation of the fourth DMC of the NATiV3 Phase III clinical trial with lanifibranor in patients with MASH/NASH
News
14 May, 2024
Redx confirms changes to Board composition
News
13 May, 2024
Inventiva's NATIVE trial data published in Nature Communications
News
13 May, 2024
May Health raises $25 million in Series B funding to advance development for Ovarian Rebalancing therapy

Moon Surgical receives second FDA clearance, covering its commercial Maestro™ surgical robotics system

Afyren provides business update on its Afyren Neoxy plant

HighLife receives IDE approval to initiate US pivotal clinical study for treatment of mitral regurgitation

GenSight Biologics appoints William Monteith to its Board of Directors

Johnson & Johnson completes acquisition of Shockwave Medical

Asahi Kasei to acquire Calliditas Therapeutics AB to accelerate growth as a global healthcare company

Elicit Plant accelerates its international expansion in response to climate change and challenges in the agricultural sector

Statement by the Board of Directors of Calliditas Therapeutics AB (publ) in relation to the public offer by Asahi Kasei Corporation

NodThera announces appointment of Daniel Swisher as Chief Executive Officer

Noema Pharma announces first patient dosed in Phase 2a Study of NOE-115, a first-in-class investigational therapy for the treatment of vasomotor symptoms and additional symptoms associated with menopause

Inspirna announces appointment of Karim Benhadji, M.D., as Chief Medical Officer and retirement of Robert Wasserman, M.D.

Qorium bolsters Board with appointment of Elizabeth Bastoni and Martin Brok, renowned experts in the consumer goods and retail sectors

Inventiva announces the positive recommendation of the fourth DMC of the NATiV3 Phase III clinical trial with lanifibranor in patients with MASH/NASH

Redx confirms changes to Board composition

Inventiva's NATIVE trial data published in Nature Communications

May Health raises $25 million in Series B funding to advance development for Ovarian Rebalancing therapy